FX.co ★ Hong Kong Stocks Hold at Near 4-Year Peak Amid Broad Gains

On Tuesday morning, the Hong Kong stock market saw an uptick of 130 points, or 0.5%, reaching 25,264. This marks the fourth consecutive session of gains, with the market maintaining its highest levels since November 2021. Gains were observed across all sectors, driven by a significant rise in U.S. futures following President Trump's announcement of a trade agreement with Japan that includes a 15% tariff. Concurrently, mainland indices surged to a three-and-a-half-year high. This upward trend was fueled by several factors, including the initiation of a $170 billion hydropower project in Tibet, easing trade tensions between the U.S. and China, and new policy initiatives from Beijing aimed at boosting critical sectors such as machinery, automotive, and electrical equipment. Investors are also attentively monitoring the upcoming Politburo meeting in China later this month, which is anticipated to outline the country's economic strategy for the remainder of the year. In other market developments, Genscript Biotech experienced a notable increase of 5.8% after projecting a return to profitability in the first half of the year. Among other leading performers were Citic Ltd. with a 2.5% gain, Innovent Biologics at 2.3%, Techtronic Industries with a 2.1% rise, and Tencent Holdings which climbed 1.6%.